Evidence check: ApoB in the context of Allergie

The evidence linking ApoB (apolipoprotein B) to allergies is weak and not established. ApoB is a core component of LDL particles and is primarily used as a marker for cardiovascular risk. Allergy pathophysiology involves IgE, Th2 cytokines, and mast cells, not directly ApoB. Some indirect connections via systemic inflammation or lipid metabolism have been speculated, but no robust human studies confirm a causal or predictive role for ApoB in allergic conditions. The provided context documents contain no relevant data on ApoB or allergies. Therefore, the evidence level is 'unclear'. Consumers should not use ApoB measurements from DNA or blood tests to assess allergy risk. A comprehensive approach including diet, gut health, and lifestyle is more appropriate, but ApoB remains a cardiovascular marker.